Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Maria Cusi and Claudia Gandolfo.
Maria Cusi
Connection Strength
2.483
Claudia Gandolfo
  1. Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay. J Clin Virol. 2021 09; 142:104942.
    View in: PubMed
    Score: 0.961
  2. SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity. Viruses. 2021 07 23; 13(8).
    View in: PubMed
    Score: 0.239
  3. Hyperimmune plasma in three immuno-deficient patients affected by non-severe, prolonged COVID-19: a single-center experience. BMC Infect Dis. 2021 Jul 01; 21(1):630.
    View in: PubMed
    Score: 0.238
  4. Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants. Vaccines (Basel). 2021 May 18; 9(5).
    View in: PubMed
    Score: 0.236
  5. How long can SARS-CoV-2 persist in human corpses? Int J Infect Dis. 2021 May; 106:1-2.
    View in: PubMed
    Score: 0.234
  6. Antibody response to SARS-CoV-2 in infected patients with different clinical outcome. J Med Virol. 2021 04; 93(4):2548-2552.
    View in: PubMed
    Score: 0.232
  7. Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020. Microbiol Resour Announc. 2020 Sep 24; 9(39).
    View in: PubMed
    Score: 0.226
  8. Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix. Eur J Cancer. 2021 10; 156:119-121.
    View in: PubMed
    Score: 0.060
  9. Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified? Int J Infect Dis. 2021 Jan; 102:299-302.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.